Vanda Pharmaceuticals Stock Forecast

Outlook: Vanda Pharmaceuticals is assigned short-term B2 & long-term Caa1 estimated rating.
AUC Score : What is AUC Score?
Short-term Tactic¹ :
Dominant Strategy :
Time series to forecast n: for Weeks²
ML Model Testing : Modular Neural Network (Emotional Trigger/Responses Analysis)
Hypothesis Testing : Lasso Regression
Surveillance : Major exchange and OTC

¹Short-term revised.

²Time series is updated based on short-term trends.

Key Points

Vanda Pharmaceuticals Inc. common stock is predicted to experience volatility driven by regulatory events and pipeline developments. A key risk is the potential for adverse outcomes in ongoing clinical trials or delayed regulatory approvals for its lead drug candidates, which could significantly impact investor sentiment and future revenue projections. Conversely, positive clinical trial data or swift regulatory approvals represent upside potential, but the market may already price in optimistic scenarios, creating a risk of disappointment if expectations are not met. Competition from existing or emerging therapies in Vanda's target indications also poses a persistent risk, potentially eroding market share and limiting pricing power. Any missteps in manufacturing or supply chain disruptions could further introduce unforeseen challenges.

About Vanda Pharmaceuticals

This exclusive content is only available to premium users.

This exclusive content is only available to premium users.

ML Model Testing

F(Lasso Regression)^6,7= $\begin{array}{cccc}{p}_{\mathrm{a}1}& p_{\mathrm{a}2}& \dots & p_{1n}\\ & ⋮\\ p_{j1}& p_{j2}& \dots & p_{jn}\\ & ⋮\\ p_{k1}& p_{k2}& \dots & p_{kn}\\ & ⋮\\ p_{n1}& p_{n2}& \dots & p_{nn}\end{array}$ X R(Modular Neural Network (Emotional Trigger/Responses Analysis))^3,4,5 X S(n):→ 6 Month $\overrightarrow{S}=\left(s_1,s_2,s_3\right)$

n:Time series to forecast

p:Price signals of Vanda Pharmaceuticals stock

j:Nash equilibria (Neural Network)

k:Dominated move of Vanda Pharmaceuticals stock holders

a:Best response for Vanda Pharmaceuticals target price

 

For further technical information as per how our model work we invite you to visit the article below: 

How do KappaSignal algorithms actually work?

Vanda Pharmaceuticals Stock Forecast (Buy or Sell) Strategic Interaction Table

Strategic Interaction Table Legend:

X axis: *Likelihood% (The higher the percentage value, the more likely the event will occur.)

Y axis: *Potential Impact% (The higher the percentage value, the more likely the price will deviate.)

Z axis (Grey to Black): *Technical Analysis%

This exclusive content is only available to premium users.

Rating	Short-Term	Long-Term Senior
Outlook	B2	Caa1
Income Statement	B3	C
Balance Sheet	C	C
Leverage Ratios	B3	B3
Cash Flow	C	Caa2
Rates of Return and Profitability	Baa2	C

*Financial analysis is the process of evaluating a company's financial performance and position by neural network. It involves reviewing the company's financial statements, including the balance sheet, income statement, and cash flow statement, as well as other financial reports and documents.
How does neural network examine financial reports and understand financial state of the company?

References

1. Hoerl AE, Kennard RW. 1970. Ridge regression: biased estimation for nonorthogonal problems. Technometrics 12:55–67
2. Bessler, D. A. S. W. Fuller (1993), "Cointegration between U.S. wheat markets," Journal of Regional Science, 33, 481–501.
3. Bottou L. 2012. Stochastic gradient descent tricks. In Neural Networks: Tricks of the Trade, ed. G Montavon, G Orr, K-R Müller, pp. 421–36. Berlin: Springer
4. Breiman L. 1996. Bagging predictors. Mach. Learn. 24:123–40
5. Chamberlain G. 2000. Econometrics and decision theory. J. Econom. 95:255–83
6. Angrist JD, Pischke JS. 2008. Mostly Harmless Econometrics: An Empiricist's Companion. Princeton, NJ: Princeton Univ. Press
7. LeCun Y, Bengio Y, Hinton G. 2015. Deep learning. Nature 521:436–44